Search research articles
Contact Us
Filters
Showing results (81-90 of 123) with videos related to
Page
of 13
Sort By:
European Neurology
|
December 22, 2012
Olfactory dysfunction in multiple sclerosis: evidence of a decrease in different aspects of olfactory function
A Rolet, E Magnin, J L Millot, et al.
Journal of the Neurological Sciences
|
July 1, 1985
Decrease of valproate-induced hyperammonemia in normal subjects by lipid ingestion
J M Warter, C Marescaux, E Hirsch, et al.
Italian Journal of Neurological Sciences
|
June 1, 1987
Multiple sclerosis diagnosis: magnetic resonance imaging compared with other instrumental examinations
L Rumbach, M Collard, J M Warter, et al.
Revue Neurologique
|
February 17, 2007
[CARIMS (Cancer Risk In Multiple Sclerosis) project: impact of long-term treatment]
C Lebrun, M Debouverie, P Vermersch, et al.
Journal of Autoimmunity
|
December 1, 1993
Treatment of multiple sclerosis with anti-CD4 monoclonal antibody. A preliminary report on B-F5 in 21 patients
E Racadot, L Rumbach, M Bataillard, et al.
Neurology
|
September 1, 1983
The renal origin of sodium valproate-induced hyperammonemia in fasting humans
J M Warter, C Brandt, C Marescaux, et al.
Epilepsia
|
October 1, 1983
Sodium valproate associated with phenobarbital: effects on ammonia metabolism in humans
J M Warter, C Marescaux, C Brandt, et al.
Molecular Pharmacology
|
September 1, 1986
Effects of sodium valproate on mitochondrial membranes: electron paramagnetic resonance and transmembrane protein movement studies
L Rumbach, C Mutet, G Cremel, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1985
HLA antigens in multiple sclerosis in Alsace
L Rumbach, M M Tongio, J M Warter, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 1, 1997
Transient multiple cranial nerve involvement as a first sign of macrophage activation syndrome
L Rumbach, E Berger, L Tatu, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 123) with videos related to
Sort By:
Page
of 13
European Neurology
|
December 22, 2012
Olfactory dysfunction in multiple sclerosis: evidence of a decrease in different aspects of olfactory function
A Rolet, E Magnin, J L Millot, et al.
Journal of the Neurological Sciences
|
July 1, 1985
Decrease of valproate-induced hyperammonemia in normal subjects by lipid ingestion
J M Warter, C Marescaux, E Hirsch, et al.
Italian Journal of Neurological Sciences
|
June 1, 1987
Multiple sclerosis diagnosis: magnetic resonance imaging compared with other instrumental examinations
L Rumbach, M Collard, J M Warter, et al.
Revue Neurologique
|
February 17, 2007
[CARIMS (Cancer Risk In Multiple Sclerosis) project: impact of long-term treatment]
C Lebrun, M Debouverie, P Vermersch, et al.
Journal of Autoimmunity
|
December 1, 1993
Treatment of multiple sclerosis with anti-CD4 monoclonal antibody. A preliminary report on B-F5 in 21 patients
E Racadot, L Rumbach, M Bataillard, et al.
Neurology
|
September 1, 1983
The renal origin of sodium valproate-induced hyperammonemia in fasting humans
J M Warter, C Brandt, C Marescaux, et al.
Epilepsia
|
October 1, 1983
Sodium valproate associated with phenobarbital: effects on ammonia metabolism in humans
J M Warter, C Marescaux, C Brandt, et al.
Molecular Pharmacology
|
September 1, 1986
Effects of sodium valproate on mitochondrial membranes: electron paramagnetic resonance and transmembrane protein movement studies
L Rumbach, C Mutet, G Cremel, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1985
HLA antigens in multiple sclerosis in Alsace
L Rumbach, M M Tongio, J M Warter, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 1, 1997
Transient multiple cranial nerve involvement as a first sign of macrophage activation syndrome
L Rumbach, E Berger, L Tatu, et al.
Page
of 13